Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000730722 | SCV000858484 | pathogenic | not provided | 2017-12-13 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003472264 | SCV004203148 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2023-10-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003472264 | SCV004413602 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2023-06-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 595224). This variant has not been reported in the literature in individuals affected with SGCA-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala348Aspfs*23) in the SGCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCA are known to be pathogenic (PMID: 9192266). |